MedPath

Effects of Diclofenac on Urethral stricture treatment pai

Phase 3
Conditions
rethral Stricture.
Urethral stricture
Registration Number
IRCT20220711055433N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Male gender
Older than 20 years old
Single urethral stricture and stricture length less than 1.5 cm

Exclusion Criteria

Urethral stricture due to Balanitis Xerotica Obliterans
History of hepatic, renal or gastric diseases
Patient refusal of participation
History of NSAID Hypersensitivity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain during urethral dilatation. Timepoint: Immediately after urethral dilatation. Method of measurement: Based on Visual Analogue Scale.;Pain 1 hour after urethral dilatation. Timepoint: 1 hour after urethral dilatation. Method of measurement: Based on Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
The need to take analgesics. Timepoint: 24 hours after urethral dilatation. Method of measurement: Yes or No.;Side effects due to Diclofenac. Timepoint: 24 hours after urethral dilatation. Method of measurement: Yes or No.
© Copyright 2025. All Rights Reserved by MedPath